EOLS
Evolus, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.86
−1.87%Forward multiples
Based on analyst estimates
- P/E forward
- 69.35x
- P/E 2026E
- —
- P/E 2027E
- 30.65x
- P/E 2028E
- 12.95x
- P/S forward
- 1.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -16.80x
- Price / sales
- 1.64x
- Price / cash flow
- -33.75x
Enterprise value
- Enterprise value
- $638.8M
- EV / sales
- 2.02x
- EV / EBITDA
- -62.44x
- EV / EBIT
- -27.54x
- Market cap
- $519.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026